12:00 AM
 | 
Oct 04, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

AIKO-150: Phase I data

A dose-escalating Phase I trial in 5 healthy volunteers administered morphine showed that 1-20 mg doses of AIKO-150...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >